Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Depreciation and Depletion (2016 - 2025)

Icu Medical (ICUI) has disclosed Depreciation and Depletion for 10 consecutive years, with $17.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation and Depletion fell 6.81% year-over-year to $17.8 million, compared with a TTM value of $69.3 million through Dec 2025, down 18.66%, and an annual FY2025 reading of $69.3 million, down 18.66% over the prior year.
  • Depreciation and Depletion was $17.8 million for Q4 2025 at Icu Medical, up from $17.7 million in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $26.4 million in Q4 2022 and bottomed at $16.3 million in Q1 2021.
  • Average Depreciation and Depletion over 5 years is $20.6 million, with a median of $21.4 million recorded in 2022.
  • The sharpest move saw Depreciation and Depletion surged 57.14% in 2022, then dropped 24.55% in 2025.
  • Year by year, Depreciation and Depletion stood at $16.8 million in 2021, then soared by 57.14% to $26.4 million in 2022, then dropped by 9.47% to $23.9 million in 2023, then decreased by 20.08% to $19.1 million in 2024, then fell by 6.81% to $17.8 million in 2025.
  • Business Quant data shows Depreciation and Depletion for ICUI at $17.8 million in Q4 2025, $17.7 million in Q3 2025, and $16.9 million in Q2 2025.